NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
215 enrolled 30 charts
SCLC
Completed
272 enrolled
Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)
Completed
45 enrolled
SKYSCRAPER-02
Phase 3 Completed
490 enrolled 31 charts
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
Completed
33 enrolled
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
Phase NA Completed
200 enrolled
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Phase 1 Completed
168 enrolled
A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC
Phase 3 Completed
585 enrolled 14 charts
A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.
Phase 1 Completed
33 enrolled
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Phase 1 Completed
23 enrolled 21 charts
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy
Phase 1/2 Completed
123 enrolled 46 charts
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC
Phase 2 Completed
107 enrolled 42 charts
Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
Phase 2 Completed
21 enrolled
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
Phase 1 Completed
134 enrolled 37 charts
A Study of AL8326 in Healthy Subjects
Phase 1 Completed
6 enrolled
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
145 enrolled 47 charts
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
Phase 2 Completed
32 enrolled 12 charts
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Phase 1/2 Completed
45 enrolled 30 charts
KEYNOTE-B99
Phase 2 Completed
126 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
Phase 2 Completed
160 enrolled 12 charts
ARAL
Completed
71 enrolled
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Phase 1/2 Completed
84 enrolled
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases
Completed
46 enrolled
LUPER
Phase 1/2 Completed
28 enrolled
Trial of NanoPac Intratumoral Injection in Lung Cancer
Phase 2 Completed
18 enrolled 12 charts
LUMINANCE
Phase 3 Completed
152 enrolled 17 charts
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
Phase 1/2 Completed
62 enrolled 29 charts
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
Phase 1 Completed
146 enrolled
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Completed
1,564 enrolled